At HIMSS26, policymakers outlined recent developments shaping health IT policy, with AI governance emerging as a central concern. Officials emphasized regulatory clarity for AI-enabled tools, balancing innovation with patient safety, transparency and bias mitigation. Discussions highlighted cross-agency coordination on oversight, updates to interoperability and data-sharing expectations, and the need for clear accountability for vendors and health systems deploying AI.
Speakers noted implications for clinicians, vendors and payers, urging standards for validation, real-world monitoring, and data provenance to support clinical trust and equitable outcomes. Providers were encouraged to invest in governance and workforce training as regulators refine guidance. The sessions underscored that policy decisions at HIMSS26 will influence adoption timelines, procurement practices and how AI is integrated into clinical workflows safely.
